返回
Stella Diagnostics Inc（SLDX）價格
SLDX 股價走勢圖
SLDX 財務
Stella Diagnostics Inc
$0.01
-0.12%
$0
收盤價：Feb 13, 16:00:00 GMT-5
$0.01
0%
$0
盤前：Feb 17, 06:27:04 GMT-5
關鍵數據
前收市價
$0.0155
開盤價
$0.014
當日範圍
$0.014 - $0.0154
52週區間
$0.0111 - $0.0585
交易量
20
平均成交量
48
每股盈餘 (TTM)
--
股息收益率
--
市值
$1.5M
什麼是 SLDX？
Stella Diagnostics, Inc. operates as a molecular diagnostics-based organization, which focuses on improving patient management strategies. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2003-07-29. The Company’s proprietary technology is based on rigorous research by domain experts and practicing physicians and can notify providers if common diseases of the esophagus like GERD and Barrett’s esophagus express proteins associated with normal or carcinogenic processes. Its panel of biomarkers and targeted proteomics method, the company can better inform gastroenterologists, surgical oncologists and pathologists which patients are high risk for disease progression into precancer or cancer. The predictive panel will be offered as a Laboratory Developed Test (LDT) in a CAP/CLIA Certified moderate complexity laboratory. Its subsidiaries include SLDX, Inc. and Galaxy Pharmaceuticals LLC.
